WalkerAndersonLongMDFACC
Pediatrics • Research Triangle Park, NCNeonatology, Pediatric Cardiology
Physician
Dr. Long is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
68 T.W. Alexander Drive
Research Triangle Park, NC 27709Phone+1 919-314-2890Fax+1 484-233-1357
Education & Training
University of North Carolina HospitalsFellowship, Pediatric Cardiology, 1981 - 1983- University of North Carolina HospitalsFellowship, Neonatal-Perinatal Medicine, 1979 - 1981
- University of North Carolina HospitalsResidency, Internal Medicine/Pediatrics, 1977 - 1979
- University of North Carolina HospitalsInternship, Internal Medicine/Pediatrics, 1976 - 1977
University of North Carolina at Chapel Hill School of MedicineClass of 1976
University of North Carolina at Chapel Hillpre medical studies, special student, 1971 - 1972- University of North Carolina at Chapel HillBA, English, Honors Program, 1967 - 1971
Certifications & Licensure
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Neonatal-Perinatal Medicine
- American Board of Pediatrics Pediatric Cardiology
Awards, Honors, & Recognition
- Pioneer Award Govenor's Commission On Reduction In Infant Mortality, Raleigh, N. Carolina, 1994
- Professional Award Pulmonary Hypertension Association, 1994
- Wellcome Scientists Lecture Burroughs Wellcome Co., 1992
- Join now to see all
Clinical Trials
- ANDES-AGI-1067 as a Novel Antidiabetic Agent Evaluation Study Start of enrollment: 2007 Aug 01
- Study of Safety, Tolerability, and Anti-Viral Effect of Locteron Compared to PEG-Intron in Patients With Chronic Hepatitis C Start of enrollment: 2008 Jan 01
- Phase 2B Dose Ranging Study of Locteron Plus Ribavirin to Treat HCV Start of enrollment: 2009 Mar 01
- Join now to see all
Publications & Presentations
PubMed
- 140 citationsEfficacy and Safety of Oral Conivaptan: A V1A/V2 Vasopressin Receptor Antagonist, Assessed in a Randomized, Placebo-Controlled Trial in Patients with Euvolemic or Hype...Jalal K. Ghali, Michael Koren, James R. Taylor, Esther Brooks-Asplund, Kaisheng Fan
The Journal of Clinical Endocrinology and Metabolism. 2006-06-01 - 63 citationsFrequency and severity of tricuspid regurgitation determined by Doppler echocardiography in primary pulmonary hypertension.Alan L. Hinderliter, Park W. Willis, Walker Long, William R. Clarke, David D. Ralph
The American Journal of Cardiology. 2003-04-15 - 574 citationsEchocardiographic predictors of adverse outcomes in primary pulmonary hypertensionRonald J. Raymond, Alan L. Hinderliter, Park W. Willis, David D. Ralph, Edgar J. Caldwell
Journal of the American College of Cardiology. 2002-04-03
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
